Skip to main content
Clinical Trials/NCT06689358
NCT06689358CompletedNot Applicable

Thoracic Paravertebral Block for Postoperative Pain Management in PACU After VATS Surgeries: A Randomized Controlled Trial

King Hussein Cancer Center1 site in 1 country81 target enrollmentStarted: November 1, 2022Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
81
Locations
1
Primary Endpoint
Opioid requirement in the PACU

Study Overview

Brief Summary

This randomized controlled trial evaluated the efficacy of a thoracic paravertebral block (TPVB) in reducing opioid requirements and pain intensity in the PACU after video-assisted thoracoscopic surgery (VATS).

Detailed Description

This randomized controlled trial evaluated the efficacy of a thoracic paravertebral block (TPVB) in reducing opioid requirements and pain intensity in the PACU after video-assisted thoracoscopic surgery (VATS). Adult patients scheduled for elective VATS who meet the eligibility criteria will be randomized to either Arm:

Arm 1: General anesthesia with TPVB;

Arm 2: General anesthesia alone (control group).

Primary Outcome: to assess Opioid requirement in the PACU

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult patients scheduled for elective VATS, ASA physical status II-III, BMI 19-40.

Exclusion Criteria

  • Patient refusal, coagulation disorders, contraindications to TPVB, chronic analgesic use, mental illness

Arms & Interventions

General anesthesia with TPVB

Experimental

0.4 ml/kg of 0.5% bupivacaine injected into the thoracic paravertebral space

Intervention: 0.4 ml/kg of 0.5% bupivacaine (Drug)

Outcomes

Primary Outcomes

Opioid requirement in the PACU

Time Frame: Opioid requirement assessed at 5 minutes, 15 minutes, 30 minutes post-PACU admission, and at PACU discharge (up to 4 hours)

Opioid requirement in the PACU, recorded as "yes" or "no."

Secondary Outcomes

  • Pain intensity measured by Numeric Rating Scale -NRS(Pain intensity measured using the Numeric Rating Scale (NRS) at 5 minutes, 15 minutes, 30 minutes post-PACU admission, and at PACU discharge (up to 4 hours))

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Thoracic Paravertebral Block for... | Clinical Trial